SP
BIIB icon

Symmetry Partners’s Biogen BIIB Stock Holding History

Symmetry Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,293
Closed -$300K – 141
2024
Q2 		$300K Hold
1,293
– – 0.02% 405
2024
Q1 		$279K Hold
1,293
– – 0.02% 438
2023
Q4 		$337K Hold
1,293
– – 0.02% 367
2023
Q3 		$332K Sell
1,293
-314
-20% -$84K 0.02% 410
2023
Q2 		$458K Sell
1,607
-671
-29% -$200K 0.02% 363
2023
Q1 		$633K Hold
2,278
– – 0.03% 268
2022
Q4 		$631K Hold
2,278
– – 0.04% 267
2022
Q3 		$608K Buy
2,278
+674
+42% +$143K 0.04% 257
2022
Q2 		$327K Buy
+1,604
New +$328K 0.02% 439
2021
Q4 		– Sell
-2,845
Closed -$798K – 606
2021
Q3 		$798K Sell
2,845
-371
-12% -$122K 0.05% 276
2021
Q2 		$1.11M Hold
3,216
– – 0.07% 203
2021
Q1 		$900K Sell
3,216
-336
-9% -$90.6K 0.06% 225
2020
Q4 		$870K Sell
3,552
-2,082
-37% -$537K 0.07% 216
2020
Q3 		$1.6M Buy
5,634
+2,944
+109% +$821K 0.14% 99
2020
Q2 		$720K Buy
+2,690
New +$809K 0.09% 94
2019
Q3 		– Sell
-1,723
Closed -$403K – 338
2019
Q2 		$403K Sell
1,723
-648
-27% -$150K 0.08% 196
2019
Q1 		$560K Buy
2,371
+617
+35% +$194K 0.1% 137
2018
Q4 		$528K Buy
+1,754
New +$560K 0.13% 101

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Symmetry Partners's BIIB Position: Q3 2024 in Review

Symmetry Partners sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,293 shares — an estimated $300K sold.

Symmetry Partners first reported a position in BIIB in Q4 2018 and held it in 18 quarters. The position peaked at $1.6M in Q3 2020. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Symmetry Partners reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 1,293 Biogen shares in Q3 2024, an estimated $300K.
  • Symmetry Partners first reported a position in Biogen in Q4 2018 and held it in 18 quarters.
  • Symmetry Partners's Biogen position peaked at $1.6M in Q3 2020.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.